Abstract

To study the relationship between glycosylated hemoglobin (HgbA1c) and myocardial perfusion in type 2 diabetes mellitus (T2DM) patients, we prospectively enrolled 24 patients with known or suspected coronary artery disease (CAD) who underwent adenosine stress by real-time myocardial perfusion echocardiography (RTMPE). HgbA1c was measured at time of RTMPE. Microbubble velocity (β min−1), myocardial blood flow (MBF, mL/min/g), and myocardial blood flow reserve (MBFR) were quantified. Quantitative MCE analysis was feasible in all patients (272/384 segments, 71%). Those with HgbA1c > 7.1% had significantly lower β reserve and MBFR than those with HgbA1c ≤ 7.1% (P < 0.05). In patients with suspected CAD, there was a significant inverse correlation between MBFR and HgbA1c (r = −0.279, P = 0.01); however, in those with known CAD, this relationship was not significant (r = −0.117, P = 0.129). Using a MBFR cutoff value > 2 as normal, HgbA1c > 7.1% significantly increased the risk for abnormal MBFR, (adjusted odds ratio: 1.92, 95% CI: 1.12–3.35, P = 0.02). Optimal glycemic control is associated with preservation of MBFR as determined by RTMPE, in T2DM patients at risk for CAD.

Highlights

  • Type 2 diabetes mellitus (T2DM) is a known risk factor of coronary artery disease (CAD)

  • We have previously shown that T2DM patients with known or suspected CAD have impaired real-time myocardial perfusion echocardiography (RTMPE)-derived quantitative myocardial perfusion parameters compared to nondiabetic patients during adenosine vasodilator stress [12]

  • We have previously shown that T2DM is associated with myocardial microvascular abnormalities as evidenced by abnormal myocardial perfusion determined by quantitative RTMPE

Read more

Summary

Introduction

Type 2 diabetes mellitus (T2DM) is a known risk factor of coronary artery disease (CAD). Glycosylated hemoglobin (HgbA1c) has been established as a risk factor for T2DM patients developing microvascular atherosclerosis [5]. The relationship between HgbA1c, coronary artery disease (CAD), and coronary perfusion in T2DM patients has not yet been clarified. Several studies have shown that HgbA1c is associated with the severity and progression of coronary atherosclerosis [7,8,9]. Each 1% reduction in HgbA1c has been shown to be associated with a 37% decrease in risk for microvascular complications and a 21% decrease in the risk of any end point or death related to diabetes [10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call